Analysis of Article 6 (tax and price measures to reduce the demand for tobacco products) of the WHO Framework Convention on Tobacco Control.


Journal

Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612

Informations de publication

Date de publication:
06 2019
Historique:
received: 24 04 2018
revised: 09 06 2018
accepted: 11 06 2018
pubmed: 27 7 2018
medline: 14 1 2020
entrez: 27 7 2018
Statut: ppublish

Résumé

To analyse the extent to which parties to the WHO Framework Convention on Tobacco Control (FCTC) have implemented Article 6 since the convention's entry into force. Compliance was measured using nine indicators, derived from the 2016 version of the FCTC's reporting instrument's core questionnaire, and the WHO's MPOWER cigarette affordability measure. Data were collected from WHO country profiles, and the 12 country mission reports by the Impact Assessment Expert Group. The number of parties reporting any type of excise tax increased from 87% (134/154) in 2008 to 92% (160/174) in 2016. Specific excise tax systems were implemented by 36% (63/174) of FCTC ratifying countries in 2016, up from 32% (49/154) in 2008. The proportion of parties with mixed tax structures has increased from 25% (39/154) in 2008 to 32% (56/174) in 2016. The proportion of parties that levy the tax as a fully ad valorem tax has decreased from 29% (45/154) in 2008 to 24% (42/174) in 2016. Cigarettes have become less affordable in 46% (78/168), more affordable in 13% (21/168) and unchanged in terms of affordability in 41% (69/168) of parties between 2008 and 2016. The number of parties that earmark tobacco tax revenues for public health increased from 13 in 2008 to 30 in 2016. Many finance ministries are hesitant to increase the excise tax, mainly due to illicit trade concerns. While there has been some improvement in tobacco tax policy over time, parties should adopt stronger tax measures, despite industry opposition and threats about illicit trade. Parties should implement FCTC Article 5.3 and ratify the Protocol to Eliminate Illicit Trade in Tobacco Products.

Identifiants

pubmed: 30045973
pii: tobaccocontrol-2018-054462
doi: 10.1136/tobaccocontrol-2018-054462
pmc: PMC6589458
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

s97-s103

Informations de copyright

© World Health Organization [year]. Licensee BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ. 2003 Jul 19;327(7407):154-7
pubmed: 12869461
Tob Control. 2004 Dec;13(4):339-46
pubmed: 15564616
Am J Public Health. 2005 Jun;95(6):936-8
pubmed: 15914812
Tob Control. 2010 Aug;19(4):325-30
pubmed: 20530141

Auteurs

Corne van Walbeek (C)

School of Economics, University of Cape Town, Rondebosch, South Africa.
Southern Africa Labour and Development Research Unit, University of Cape Town, Rondebosch, South Africa.

Samantha Filby (S)

Southern Africa Labour and Development Research Unit, University of Cape Town, Rondebosch, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH